Sea You at Fetch Long Beach
|Articles|August 1, 2009

Intensity modulated radiation therapy: The future is now (Proceedings)

Intensity Modulated Radiation Therapy (IMRT) is a method of 3-D conformal therapy using a computer controlled multi-leaf collimator.

Intensity Modulated Radiation Therapy (IMRT) is a method of 3-D conformal therapy using a computer controlled multi-leaf collimator. The benefit of this type of therapy over fixed-leaf collimators is the improved conformality of dose distribution across the field do to the ability to divide each beam into segments. This proves particularly helpful when treating tumors that in the past have been poor to minimally responsive to radiation therapy due to the presence of critical structures within the field and their associated dose-limiting parameters. Utilization of IMRT changes how radiation therapy treatments are planned, helps to improve treatment outcomes, and assists in decreasing patient side effects.

Treatment planning involves the use of advanced imaging such as computed tomography (CT). Patients are placed on the CT couch in an appropriate positioning device in the exact position they will receive their therapy. Once completed, the images are sent to the treatment planning computer where regions of interest are highlighted and the tumor is prescribed by the radiation oncologist and/or physicist. The computer can then do the dose calculations to determine how much radiation will be received by normal and affected tissue alike. Appropriate adjustments can be made accordingly prior to the start of therapy, assuring adequate dose to the tumor and acceptable dose to surrounding tissue.

IMRT plans use multiple beams circling the patient around a 360-degree arc. IMRT can specifically control ("modulate") the weights of portions within each individual radiation beam. This is called " intensity distribution" and is how the beam is shaped into the complex three-dimensional form of the tumor volume being targeted. This further allows for non-uniform fluence (beam intensity) to the patient, so critical structures/tissues may be spared while malignant tissue may receive the optimal treatment dose.


Related to this article

Laverdia now available for purchase for dogs with lymphoma
Verdinexor tablets are now available for dogs with lymphoma after receiving full FDA approval earlier this year, offering an at-home treatment option given twice weekly and showing a longer time to disease progression than the control in a field study.
Q&A: Caregiver burden can begin early in pet illness. Are veterinary teams equipped to support clients, and how can veterinary social workers help both parties?
Caroline Cox, LSW, MSW, and Erika Krick, VMD, DACVIM (Oncology), discuss the role of veterinary social workers in supporting clients, communicating with veterinary teams, and helping practices address the human side of veterinary care in this Q&A from an interview at the 2026 Fetch National Harbor Veterinary Conference.
Inside veterinary social work
In a slideshow drawn from an on-site dvm360 interview at the 2026 Fetch National Harbor Veterinary Conference, a veterinary oncologist and a veterinary social worker walk through how the role supports owners and staff across a pet's cancer diagnosis, treatment, and end-of-life care.